Volume 1 · Issue 5

Neurodegeneration & the Aging Brain

From cognitive reserve to longitudinal biomarkers, this issue examines the progression of neurodegenerative conditions and the evidence used to distinguish aging from disease.

100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief

Issue 5 · Reading list

Explore the research

Download issue catalog

100 readings · Page 2 of 5

  1. Parkinson’s disease and related disorders · CC BY 4.0

    Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

    GBD 2016 Parkinson's Disease Collaborators

    The Lancet. Neurology · 2018

    Original article
  2. Parkinson’s disease and related disorders · CC BY 4.0

    The SH-SY5Y cell line in Parkinson's disease research: a systematic review.

    Helena Xicoy, Helena Xicoy, Bé Wieringa, Gerard J M Martens

    Molecular neurodegeneration · 2017

    Original article
  3. Parkinson’s disease and related disorders · CC BY 4.0

    The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.

    Gregor K Wenning, Iva Stankovic, Luca Vignatelli, Alessandra Fanciulli et al.

    Movement disorders : official journal of the Movement Disorder Society · 2022

    Original article
  4. Parkinson’s disease and related disorders · CC BY 4.0

    Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.

    Martin Steger, Francesca Tonelli, Genta Ito, Paul Davies et al.

    eLife · 2016

    Original article
  5. Parkinson’s disease and related disorders · CC BY 4.0

    Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.

    Klaus Seppi, K Ray Chaudhuri, Miguel Coelho, Susan H Fox et al.

    Movement disorders : official journal of the Movement Disorder Society · 2019

    Original article
  6. Parkinson’s disease and related disorders · CC BY 4.0

    Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.

    Paolo Calabresi, Alessandro Mechelli, Giuseppina Natale, Laura Volpicelli-Daley et al.

    Cell death & disease · 2023

    Original article
  7. Parkinson’s disease and related disorders · CC BY 4.0

    Neuroinflammation in Parkinson's disease and its potential as therapeutic target.

    Qinqin Wang, Yingjun Liu, Jiawei Zhou

    Translational neurodegeneration · 2015

    Original article
  8. Parkinson’s disease and related disorders · CC BY 4.0

    Prevalence of Parkinson's disease across North America.

    C Marras, J C Beck, J H Bower, E Roberts et al.

    NPJ Parkinson's disease · 2018

    Original article
  9. Parkinson’s disease and related disorders · CC BY 3.0

    Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

    Amy Reeve, Eve Simcox, Doug Turnbull

    Ageing research reviews · 2014

    Original article
  10. Parkinson’s disease and related disorders · CC BY 4.0

    Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.

    Stefano Romano, George M Savva, Janis R Bedarf, Ian G Charles et al.

    NPJ Parkinson's disease · 2021

    Original article
  11. Parkinson’s disease and related disorders · CC BY 4.0

    Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment.

    Ryosuke Kojima, Daniel Bojar, Giorgio Rizzi, Ghislaine Charpin-El Hamri et al.

    Nature communications · 2018

    Original article
  12. Parkinson’s disease and related disorders · CC BY 4.0

    Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease.

    Tushar Kamath, Abdulraouf Abdulraouf, S J Burris, Jonah Langlieb et al.

    Nature neuroscience · 2022

    Original article
  13. Parkinson’s disease and related disorders · CC BY 4.0

    Oxidative stress and Parkinson's disease.

    Javier Blesa, Ines Trigo-Damas, Anna Quiroga-Varela, Vernice R Jackson-Lewis

    Frontiers in neuroanatomy · 2015

    Original article
  14. Parkinson’s disease and related disorders · CC BY 4.0

    Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.

    Marta Pajares, Ana I Rojo, Gina Manda, Lisardo Boscá et al.

    Cells · 2020

    Original article
  15. Original article
  16. Parkinson’s disease and related disorders · CC BY 4.0

    Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.

    Benjamin G Trist, Dominic J Hare, Kay L Double

    Aging cell · 2019

    Original article
  17. Parkinson’s disease and related disorders · CC BY 4.0

    Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.

    J R Bedarf, F Hildebrand, L P Coelho, S Sunagawa et al.

    Genome medicine · 2017

    Original article
  18. Parkinson’s disease and related disorders · CC BY 4.0

    The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis.

    Heather D E Booth, Warren D Hirst, Richard Wade-Martins

    Trends in neurosciences · 2017

    Original article
  19. Parkinson’s disease and related disorders · CC BY 2.5

    Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.

    YaXing Gui, Hai Liu, LiShan Zhang, Wen Lv et al.

    Oncotarget · 2015

    Original article
  20. Parkinson’s disease and related disorders · CC BY 4.0

    Current and projected future economic burden of Parkinson's disease in the U.S.

    Wenya Yang, Jamie L Hamilton, Catherine Kopil, James C Beck et al.

    NPJ Parkinson's disease · 2020

    Original article